Atyr Pharma Inc (ATYR) Ordinary Shares

Sell:$0.47Buy:$0.47Price decreased$0.04 (8.38%)

Market closed |
Prices delayed by at least 15 minutes
Sell:$0.47
Buy:$0.47
Change:Price decreased$0.04 (8.38%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$0.47
Buy:$0.47
Change:Price decreased$0.04 (8.38%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
27 May 2026
Paul Reinhard SchimmelOther Level A
Buy
Regular purchase transaction
100,000$0.50$49,630.00779,143
4 February 2026
Sanjay S. ShuklaPresident/CEO
Sell
Tax related
3,745$0.98$3,655.49153,553
4 February 2026
Jill Marie BroadfootCFO
Sell
Tax related
1,558$0.98$1,520.7637,296
4 February 2026
Nancy E. DenyesCompany Secretary
Sell
Tax related
1,118$0.98$1,091.2833,124
9 October 2025
Paul Reinhard SchimmelOther Level A
Buy
Regular purchase transaction
317,999$0.94$299,364.261,413,023
8 October 2025
Paul Reinhard SchimmelOther Level A
Buy
Regular purchase transaction
682,001$0.90$612,436.901,095,024

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
8 October 2025
Paul Reinhard SchimmelOther Level A
Buy
Regular purchase transaction
682,001$0.90$612,436.901,095,024
9 October 2025
Paul Reinhard SchimmelOther Level A
Buy
Regular purchase transaction
317,999$0.94$299,364.261,413,023
27 May 2026
Paul Reinhard SchimmelOther Level A
Buy
Regular purchase transaction
100,000$0.50$49,630.00779,143
4 February 2026
Sanjay S. ShuklaPresident/CEO
Sell
Tax related
3,745$0.98$3,655.49153,553
4 February 2026
Jill Marie BroadfootCFO
Sell
Tax related
1,558$0.98$1,520.7637,296

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.